LeMaitre Vascular Inc (LMAT) NPV

Sell:$100.53Buy:$100.91$0.74 (0.74%)

NASDAQ:0.24%
Prices delayed by at least 15 minutes
Sell:$100.53
Buy:$100.91
Change:$0.74 (0.74%)
Prices delayed by at least 15 minutes
Sell:$100.53
Buy:$100.91
Change:$0.74 (0.74%)
Prices delayed by at least 15 minutes

Company Information

About this company

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.

Key people

George W. Lemaitre
Chairman of the Board, Chief Executive Officer
David Brian Roberts
President, Director
Joseph P. Pellegrino
Director
Maik D. Helmers
Senior Vice President - Sales, Central Europe
Ryan H. Connelly
Senior Vice President - Advanced Manufacturing Engineering
Andrew Hodgkinson
Senior Vice President - Clinical, Regulatory, Quality Affairs
Trent G. Kamke
Senior Vice President - Operations
Stephane Maier
Senior Vice President, Operations - EMEA
Jacob Petersen
Senior Vice President, International
David Hissong
Vice President, General Counsel
Lawrence J. Jasinski
Independent Director
John J. O'Connor
Independent Director
Bridget A. Ross
Independent Director
John A. Roush
Independent Director
Martha Shadan
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US5255582018
  • Market cap
    $2.25bn
  • Employees
    614
  • Shares in issue
    24.07m
  • Exchange
    NASDAQ
  • Index
    S&P 600 Small Cap, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.